Eyewash Station Additive Concentrate
- Product NDC
- 65785-034
- Requested package NDC
- 65785-034-01
- 11-digit product format
- 657850034
- Labeler code
- 65785
- Product ID
- 65785-034_445cd72e-831c-98c4-e063-6294a90a7bdc
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Chlorhexidine gluconate and Propylene Glycol
- Dosage form
- LIQUID
- Route
- OPHTHALMIC
- Labeler
- Niagara Pharmaceuticals Inc.
- Application
- M018
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2011-11-15
- Substance
- CHLORHEXIDINE GLUCONATE; PROPYLENE GLYCOL
- Active strength
- 145.6; 280 kg/2800L; kg/2800L
- Pharmacologic classes
- Decreased Cell Wall Integrity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 65785-034 | 65785-034-01 | U | Excluded because listing certification expired | excluded / ndc_excluded.zip | 0efc9e666f02… | f202fb6c5f17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Eyewash Station Additive Concentrate
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| CHLORHEXIDINE GLUCONATE | 145.6 kg/2800L |
| PROPYLENE GLYCOL | 280 kg/2800L |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| MOR84MUD8E | Internal UNII lookup |
| 6DC9Q167V3 | Internal UNII lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362a6b6d-862d-4322-87a8-5b3a07fbe174 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 6c13b22c-b3ba-4127-b768-0132dd5ab0d1 | Product name | 1 | 20230829 |
| bb6d6c68-649d-4e6d-a1f6-603d969c8f68 | Product name | 1 | 20160303 |
FDA-Initiated Inactive NDC Indexing#
| Effective | Related label |
|---|---|
| 2023-02-21 | EYEWASH STATION ADDITIVE CONCENTRATE |
| 2023-02-21 | EYEWASH STATION ADDITIVE CONCENTRATE |
| 2023-01-30 | EYEWASH STATION ADDITIVE CONCENTRATE |
| 2023-01-30 | EYEWASH STATION ADDITIVE CONCENTRATE |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 65785-034-01 | Eyewash Station Additive Concentrate | 0.236 L in 1 BOTTLE, UNIT-DOSE | LIQUID | 0.236 | 8 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Chlorhexidine gluconate | ACTIVE INGREDIENT | MOR84MUD8E | EYEWASH STATION ADDITIVE CONCENTRATE (CHLORHEXIDINE GLUCONATE AND PROPYLENE GLYCOL) LIQUID [NIAGARA PHARMACEUTICALS INC.] | 1 | |
| Propylene Glycol | ACTIVE INGREDIENT | 6DC9Q167V3 | EYEWASH STATION ADDITIVE CONCENTRATE (CHLORHEXIDINE GLUCONATE AND PROPYLENE GLYCOL) LIQUID [NIAGARA PHARMACEUTICALS INC.] | 1 | |
| Chlorhexidine | ACTIVE MOIETY | R4KO0DY52L | EYEWASH STATION ADDITIVE CONCENTRATE (CHLORHEXIDINE GLUCONATE AND PROPYLENE GLYCOL) LIQUID [NIAGARA PHARMACEUTICALS INC.] | 1 | |
| Propylene Glycol | ACTIVE MOIETY | 6DC9Q167V3 | EYEWASH STATION ADDITIVE CONCENTRATE (CHLORHEXIDINE GLUCONATE AND PROPYLENE GLYCOL) LIQUID [NIAGARA PHARMACEUTICALS INC.] | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | EYEWASH STATION ADDITIVE CONCENTRATE (CHLORHEXIDINE GLUCONATE AND PROPYLENE GLYCOL) LIQUID [NIAGARA PHARMACEUTICALS INC.] | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 65785-034 | EYEWASH STATION ADDITIVE CONCENTRATE (CHLORHEXIDINE GLUCONATE AND PROPYLENE GLYCOL) LIQUID [NIAGARA PHARMACEUTICALS INC.] | 5 | Current NDC, Legacy NDC, 1 package rows | 20250115_362a6b6d-862d-4322-87a8-5b3a07fbe174.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Eyewash Station Additive Concentrate | CHLORHEXIDINE GLUCONATE AND PROPYLENE GLYCOL | Encon Safety Products, Inc. | b5a62567-c9f1-0492-e053-2a95a90ab247 | 2026-11-05 | Warnings | M018 |
| Visine Red Eye Total Comfort Multi-Symptom | TETRAHYDROZOLINE HYDROCHLORIDE, POLYETHYLENE GLYCOL 400, AND ZINC SULFATE, UNSPECIFIED FORM | Kenvue Brands LLC | 5747edef-7a87-41d7-9594-6c78508b9ba2 | 2026-11-04 | Warnings | M018 |
| ENCON EYEWASH | EYEWASH | Encon Safety Products, Inc. | 485c691e-f6a8-4836-e063-6294a90a16fc | 2026-10-29 | Warnings | M018 |
| Optase | GLYCERIN | Scope Health Inc | d81c1a4f-87b0-ee8c-e053-2995a90af9e5 | 2026-10-25 | Warnings | M018 |
| Optase Allegro | HYDROXYETHYL CELLULOSE | Scope Health Inc | f7999928-f5c1-98d6-e053-6294a90a57db | 2026-10-25 | Warnings | M018 |
| Optase | WHITE PETROLATUM, LANOLIN | Scope Health Inc | c1991caa-51b9-13d1-e053-2995a90a1293 | 2026-10-25 | Warnings | M018 |
| Optase | GLYCERIN | Scope Health Inc | 9e96976b-2990-79e0-e053-2995a90a0f29 | 2026-10-25 | Warnings | M018 |
| Optase | GLYCERIN | Scope Health Inc | 376e0289-28e9-e87f-e063-6294a90a3b04 | 2026-10-25 | Warnings | M018 |
| Optase | GLYCERIN | Scope Health Inc | f452a2c4-c869-7bf5-e053-2995a90ac1a0 | 2026-10-25 | Warnings | M018 |
| Optase | GLYCERIN | Scope Health Inc | 10c3e31d-779d-8ff6-e063-6294a90acd39 | 2026-10-25 | Warnings | M018 |
| Optase | GLYCERIN | Scope Health Inc | 86c14327-ffc7-806e-e053-2991aa0aaf92 | 2026-10-25 | Warnings | M018 |
| Clear Eyes Maximum Redness Relief | NAPHAZOLINE HYDROCHLORIDE AND GLYCERIN | Prestige Brands Holdings, Inc. | c3b0e344-68dd-4c35-bf46-744e612a5b15 | 2026-10-23 | Warnings | M018 |
| Clear Eyes Triple Relief | POLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDE | Prestige Brands Holdings, Inc. | 1269a1a6-843d-4d08-bb3c-c1f3d2e7080d | 2026-10-23 | Warnings | M018 |
| Fendall 1000 Pure Flow | PURIFIED WATER | Protective Industrial Products, Inc. | 55a2f4da-bb1e-8ead-e063-6394a90af72e | 2026-10-21 | Warnings | M018 |
| Walgreens Sterile Soothing Eye Wash | PURIFIED WATER | Walgreens | a62e3294-abd6-48dc-81b1-62a809bdc968 | 2026-10-19 | Warnings | M018 |
| Visine Red Eye Hydrating Comfort | TETRAHYDROZOLINE HYDROCHLORIDE AND POLYETHYLENE GLYCOL 400 SOLUTION/ DROPS | Select Consumer Group | 5e153070-3668-f3c7-e063-6294a90a373b | 2026-10-17 | Warnings | M018 |
| Rohto Max Strength | NAPHAZOLINE HYDROCHLORIDE, POLYSORBATE 80 | The Mentholatum Company | e4b49550-1ca3-4bd7-854d-409b53fa5e26 | 2026-10-16 | Warnings | M018 |
| TheraTears Extra | CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM | MEDTECH PRODUCTS INC | 77f504c1-b8e0-4371-ac3e-9d453d84714b | 2026-10-15 | Warnings | M018 |
| TheraTears Extra | CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED | MEDTECH PRODUCTS INC | f1845041-9d8d-42a0-a2cb-68def7a5aac7 | 2026-10-15 | Warnings | M018 |
| TheraTears Lubricant | CARBOXYMETHYLCELLULOSE SODIUM | MEDTECH PRODUCTS INC | 797b0394-2f0f-4733-8d20-ec5bdf3e085d | 2026-10-15 | Warnings | M018 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 65785-034-01 | 65785003401 | .236 L in 1 BOTTLE, UNIT-DOSE (65785-034-01) | 2011-11-15 | 0000-00-00 | No | No | Current |